Pulmonary Arterial Hypertension: all 773 studies

Page 8 of 8. Open to participants first (142), then studies with results posted, then the rest; newest registration first within each.

• Post Marketing Observational Study in Patients With Pulmonary Arterial HypertensionCompletedNCT01066845
• Hypertension Study of Ventavis® Inhalation Therapy in the Treatment of Patients With Pulmonary Arterial Hypertension (VENIS)CompletedNCT01062282
• Effect of BMPR-2 Gene Mutations on Hemodynamic Response by Iloprost Inhalation in Pulmonary Arterial HypertensionCompletedNCT01054105
• Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)CompletedNCT01043627
• Multidisciplinary Collaboration Care in Pulmonary Arterial Hypertension (PAH)CompletedNCT01038284Not applicable
• Study of ACT-293987 (NS-304) in Pulmonary Arterial Hypertension (PAH)CompletedNCT00993408Phase 2
• Effect of Esomeprazole on the Pharmacokinetics of Oral TreprostinilCompletedNCT00963027Phase 1
• Effect of Food on the Pharmacokinetics of Oral TreprostinilCompletedNCT00963001Phase 1
• Biomarkers in the Evaluation of Chronic Lung DiseaseCompletedNCT00926523
• Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative DiseasesCompletedNCT00909467
• Early Therapy of Pulmonary Arterial HypertensionCompletedNCT00909337Not applicable
• Ventavis® Registry ProtocolTerminatedNCT00902603
• Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH)CompletedNCT00882947
• Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 StudyNo longer availableNCT00878943
• Local Open-Label Access Study For Patients Who Completed A1481244 Study In BrazilNo longer availableNCT00866983
• A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue DiseaseStatus unknownNCT00864201Phase 3
• Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)TerminatedNCT00832507Phase 2
• Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy VolunteersCompletedNCT00814645Phase 1
• Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular FailureWithdrawnNCT00811486Not applicable
• The Expression and Significance of MiRNACompletedNCT00806312
• Study Evaluating the Addition of Sildenafil to Bosentan Therapy in Pulmonary Arterial HypertensionWithdrawnNCT00780728Phase 3
• FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)WithdrawnNCT00760916Phase 3
• The Assessment of Right Ventricular Contractility in Response to SildenafilTerminatedNCT00742014Phase 3
• Reversible Secondary Myelofibrosis or Clonal Myeloproliferative DisorderTerminatedNCT00722254
• The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial HypertensionCompletedNCT00718952Phase 3
• Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)TerminatedNCT00706082
• Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.Status unknownNCT00705588Phase 4
• A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial HypertensionCompletedNCT00644605Phase 3
• Safety and Feasibility of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic Pulmonary Arterial HypertensionCompletedNCT00641836Not applicable
• Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With BosentanWithdrawnNCT00625469Phase 4
• Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With SildenafilWithdrawnNCT00625079Phase 4
• Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung ScansCompletedNCT00621075
• Pulmonary Arterial Hypertension in Systemic SclerosisStatus unknownNCT00617487
• The Early Recognition of Pulmonary Arterial HypertensionCompletedNCT00609349Not applicable
• Pharmacogenomics in Pulmonary Arterial HypertensionWithdrawnNCT00593905
• Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger PatientsTerminatedNCT00586794Phase 3
• Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary HypertensionCompletedNCT00581607Phase 2/3
• Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH)CompletedNCT00566423Not applicable
• Rehabilitation for Patients With Pulmonary Arterial HypertensionStatus unknownNCT00544726Not applicable
• Is There Intravascular Hemolysis in Patients With Pulmonary Hypertension?Status unknownNCT00502398
• Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial HypertensionTerminatedNCT00494533Phase 4
• Hemodynamic Response After Six Months of SildenafilStatus unknownNCT00483626Phase 4
• Pulmonary Hypertension: Assessment of Cell TherapyCompletedNCT00469027Phase 1
• Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial HypertensionWithdrawnNCT00453414Phase 2
• Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)CompletedNCT00452218Phase 1
• 6R-BH4 Pulmonary Arterial Hypertension StudyCompletedNCT00435331Phase 1
• Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.CompletedNCT00423748Phase 3
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.CompletedNCT00423202Phase 3
• Inhaled Iloprost for Sarcoidosis-associated Pulmonary HypertensionCompletedNCT00403650Phase 4
• Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma PatientsCompletedNCT00377949
• Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial HypertensionStatus unknownNCT00372346Not applicable
• Pulmonary Hypertension in Patients With Sickle Cell Disease in NigeriaCompletedNCT00367523
• Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial HypertensionWithdrawnNCT00323024Phase 2
• Bosentan in Children With Pulmonary Arterial HypertensionCompletedNCT00319267Phase 3
• Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger PhysiologyCompletedNCT00317486Phase 4
• Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)TerminatedNCT00310830Phase 3
• Bosentan in Treatment of Pulmonary Arterial HypertensionCompletedNCT00266162Phase 4
• Effects of Bosentan (Tracleer) in the Course of Pulmonary Artery Hypertension Induced by HypoxiaCompletedNCT00260819Phase 1
• Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial HypertensionCompletedNCT00257413Not applicable
• Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 YearsCompletedNCT00250640
• Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial HypertensionCompletedNCT00240656Phase 1
• Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary HypertensionStatus unknownNCT00173537Not applicable
• Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial HypertensionCompletedNCT00159887Phase 3
• PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial HypertensionCompletedNCT00125918Phase 3
• Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)TerminatedNCT00120380Phase 4
• A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial HypertensionCompletedNCT00105209Phase 2
• Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class IICompletedNCT00091715Phase 3
• ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)CompletedNCT00091598Phase 3
• Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)CompletedNCT00086463Phase 2
• Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial HypertensionCompletedNCT00080457Phase 3
• A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial HypertensionCompletedNCT00058929Phase 4
• Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial HypertensionCompletedNCT00046319Phase 2
• Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial HypertensionStatus unknownNCT00034307Phase 2/3

← Pulmonary Arterial Hypertension overview